Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Psychological correlates of obesity in women

International Journal of Obesity volume 31, pages S14–S18 (2007)Cite this article

Abstract

Psychological comorbidity is high in patients with obesity and is associated with a variety of medical and dietary problems as well as demographic, social and cognitive risk factors. Young overweight and obese women are at particular risk for developing sustained depressive mood, which is an important gateway symptom for major depressive disorder. Increased knowledge of behavioural risk factors has enabled patients with obesity to be classified on a psychological basis and this needs to be considered as part of a patient's clinical assessment and treatment strategy. Increased awareness of abnormal eating behaviour, together with profiling of personality traits, could improve treatment selection for obese women and improve the outcome of weight-loss programmes. Individualised antiobesity drug therapy may be required depending on the patient's psychological characteristics.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Tuthill A, Slawik H, O'Rahilly S, Finer N . Psychiatric co-morbidities in patients attending specialist obesity services in the UK. Q J Med 2006; 99: 317–325.

    Article  CAS  Google Scholar 

  2. Heo M, Pietrobelli A, Fontaine KR, Sirey JA, Faith MS . Depressive mood and obesity in US adults: comparison and moderation by sex, age, and race. Int J Obes 2006; 30: 513–519.

    Article  CAS  Google Scholar 

  3. Friedman MA, Brownell KD . Psychological correlates of obesity: moving to the next research generation. Psychol Bull 1995; 117: 3–20.

    Article  CAS  Google Scholar 

  4. Gibbons LM, Sarwer DB, Crerand CE, Fabricatore AN, Kuehnel RH, Lipschutz PE et al. Previous weight loss experience of bariatric surgery candidates: how much have patients dieted prior to surgery? Obesity 2006; 14 (Suppl 2): 70S–76S.

    Article  Google Scholar 

  5. Elfhag K, Rossner S . Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain. Obes Rev 2005; 6: 67–85.

    Article  CAS  Google Scholar 

  6. Field AE, Aneja P, Austin SB, Shrier LA, de Moor C, Gordon-Larsen P . Race and gender differences in the association of dieting and gains in BMI among young adults. Obesity 2007; 15: 456–464.

    Article  Google Scholar 

  7. Elfhag K, Rossner B, Barkeling B, Rooth P . Sibutramine treatment in obesity: initial eating behaviour in relation to weight loss results and changes in mood. Pharmacol Res 2005; 51: 159–163.

    Article  CAS  Google Scholar 

  8. Hainer V, Kunesova M, Bellisle F, Hill M, Braunerova R, Wagenknecht M, STO Study Group. Psychobehavioural and nutritional predictors of weight loss in obese women treated with sibutramine. Int J Obes 2005; 29: 208–216.

    Article  CAS  Google Scholar 

  9. Elfhag K, Finer N, Rossner S . Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success. Diabetes Obes Metab [e-pub ahead of print: 26 June 2007; doi:10.1111/j.1463-1326.2007.00740.x].

    Article  CAS  Google Scholar 

  10. Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM et al. Sibutramine produces dose-related weight loss. Obes Res 1999; 7: 189–198.

    Article  CAS  Google Scholar 

  11. Finer N, Ryan DH, Renz CL, Hewkin AC . Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients. Diabetes Obes Metab 2006; 8: 206–213.

    Article  CAS  Google Scholar 

  12. Hansen D, Astrup A, Toubro S, Finer N, Kopelman P, Hilsted J, et al., For the STORM study group. Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Int J Obes Relat Metab Disord 2001; 25: 496–501.

    Article  CAS  Google Scholar 

  13. Elfhag K, Rossner S, Carlsson AM, Barkeling B . Sibutramine treatment in obesity: predictors of weight loss including Rorschach personality data. Obes Res 2003; 11: 1391–1399.

    Article  CAS  Google Scholar 

  14. Kaukua JK, Pekkarinen TA, Rissanen AM . Health-related quality of life in a randomised placebo-controlled trial of sibutramine in obese patients with type II diabetes. Int J Obes Relat Metab Disord 2004; 28: 600–605.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Molecular and Metabolic Research Unit, University of Pretoria, Pretoria, Republic of South Africa

    M-T van der Merwe

Authors
  1. M-T van der Merwe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M-T van der Merwe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van der Merwe, MT. Psychological correlates of obesity in women. Int J Obes 31 (Suppl 2), S14–S18 (2007). https://doi.org/10.1038/sj.ijo.0803731

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803731

Keywords

This article is cited by

Search

Advanced search

Quick links